Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 1,946,667 | 1,841,667 | -105,000 | $163.36M | $179.53M | 16.48% | +$16.16M |
| Definium Therapeutics, Inc.(DFTX) | 2,440,000 | 2,950,000 | +510,000 | $46.12M | $138.77M | 12.74% | +$92.65M |
| ABIVAX Société AnonymeADS(ABVX) | 677,000 | 993,000 | +316,000 | $75.38M | $132.33M | 12.15% | +$56.94M |
| Cogent Biosciences, Inc.(COGT) | 2,350,000 | 2,350,000 | 0 | $90.45M | $90.94M | 8.35% | +$493.5K |
| Alumis Inc | 2,830,700 | 2,830,700 | 0 | $62.36M | $79.66M | 7.31% | +$17.30M |
| ArriVent BioPharma, Inc.(AVBP) | 1,971,054 | 1,971,054 | 0 | $45.47M | $68.47M | 6.28% | +$23.00M |
| Taysha Gene Therapies, Inc.(TSHA) | 8,859,911 | 9,693,244 | +833,333 | $39.60M | $66.01M | 6.06% | +$26.41M |
| BioAge Labs, Inc.(BIOA) | 1,748,000 | 1,748,000 | 0 | $30.57M | $42.84M | 3.93% | +$12.27M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 338,900 | 338,900 | 0 | $31.31M | $39.68M | 3.64% | +$8.37M |
| Kymera Therapeutics, Inc.(KYMR) | 425,000 | 310,000 | -115,000 | $35.40M | $35.55M | 3.26% | +$149.4K |
| Aktis Oncology, Inc.(AKTS) | 960,847 | 960,847 | 0 | $17.19M | $30.97M | 2.84% | +$13.78M |
| Xenon Pharmaceuticals Inc.(XENE) | 490,000 | 490,000 | 0 | $28.49M | $29.58M | 2.71% | +$1.08M |
| Palisade Bio, Inc.(PALI) | 10,276,317 | 10,276,317 | 0 | $17.98M | $21.48M | 1.97% | +$3.49M |
| Ocular Therapeutix, Inc.(OCUL) | 3,166,600 | 2,075,000 | -1,091,600 | $26.82M | $20.38M | 1.87% | -$6.44M |
| Disc Medicine, Inc.(IRON) | 270,000 | 270,000 | 0 | $17.26M | $19.75M | 1.81% | +$2.48M |
| Summit Therapeutics Inc.(SMMT) | 0 | 1,250,000 | +1,250,000 | $0 | $18.21M | 1.67% | +$18.21M |
| Pharvaris N V COM | 165,000 | 456,721 | +291,721 | $4.66M | $15.79M | 1.45% | +$11.13M |
| Adlai Nortye Group Ltd.ADS(ANL) | 0 | 934,716 | +934,716 | $0 | $10.75M | 0.99% | +$10.75M |
| Precision BioSciences, Inc.(DTIL) | 2,236,732 | 1,350,000 | -886,732 | $12.30M | $10.61M | 0.97% | -$1.69M |
| DBV Technologies S.A.ADS(DBVT) | 574,200 | 574,200 | 0 | $12.00M | $9.42M | 0.86% | -$2.58M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 361,010 | +361,010 | $0 | $9.03M | 0.83% | +$9.03M |
| Gyre Therapeutics, Inc.(GYRE) | 0 | 954,416 | +954,416 | $0 | $6.29M | 0.58% | +$6.29M |
| Trevi Therapeutics, Inc.(TRVI) | 1,485,000 | 315,000 | -1,170,000 | $17.72M | $5.87M | 0.54% | -$11.84M |
| Unicycive Therapeutics, Inc.(UNCY) | 1,000,000 | 1,000,000 | 0 | $6.58M | $4.69M | 0.43% | -$1.89M |
| Context Therapeutics Inc.(CNTX) | 5,250,000 | 3,050,000 | -2,200,000 | $13.76M | $1.69M | 0.16% | -$12.07M |
| Gossamer Bio, Inc.(GOSS) | 7,750,000 | 7,750,000 | 0 | $2.55M | $1.28M | 0.12% | -$1.27M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 719,000 | 0 | -719,000 | $6.44M | $0 | — | -$6.44M |
| Centessa Pharmaceuticals PlcADS | 750,000 | 0 | -750,000 | $29.79M | $0 | — | -$29.79M |
| Evommune, Inc.(EVMN) | 143,472 | 0 | -143,472 | $3.30M | $0 | — | -$3.30M |
| Kalvista Pharmaceuticals Inc | 1,450,000 | 0 | -1,450,000 | $29.19M | $0 | — | -$29.19M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,100,000 | 0 | -1,100,000 | $6.31M | $0 | — | -$6.31M |
| Perspective Therapeutics, Inc.(CATX) | 791,555 | 0 | -791,555 | $3.30M | $0 | — | -$3.30M |
| Terns Pharmaceuticals Inc | 530,000 | 0 | -530,000 | $27.94M | $0 | — | -$27.94M |